Literature DB >> 16157221

Tenascin-C promotes cell survival by activation of Akt in human chondrosarcoma cell.

Jun-Hyeog Jang1, Chong-Pyoung Chung.   

Abstract

Tenascin-C (TnC) is an extracellular matrix protein that is highly expressed in tumor stroma. In this report, we examined the roles of TnC-mediated cell adhesion in the modulation of chondrosarcoma cell survival. We found that hTnC-mediated adhesion could confer a significant (P<0.05) survival advantage to human chondrosarcoma cell line, JJ012, following serum-deprivation compared with the same cells grown on poly-lysine. This pro-survival signal was due to the activation of the Akt upon adhesion to hTnC. Moreover, hTnC-induced Akt activation was blocked by LY294002 and the expression of dominant-negative Akt. Taken together, these studies support that the TnC-mediated adhesion can promote cell survival through Akt in human chondrosarcoma cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157221     DOI: 10.1016/j.canlet.2004.12.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

Review 1.  The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.

Authors:  Alphonse E Sirica
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-29       Impact factor: 46.802

Review 2.  Cartilage tumours and bone development: molecular pathology and possible therapeutic targets.

Authors:  Judith V M G Bovée; Pancras C W Hogendoorn; Jay S Wunder; Benjamin A Alman
Journal:  Nat Rev Cancer       Date:  2010-06-10       Impact factor: 60.716

Review 3.  The functional role of reactive stroma in benign prostatic hyperplasia.

Authors:  Isaiah G Schauer; David R Rowley
Journal:  Differentiation       Date:  2011-06-12       Impact factor: 3.880

4.  The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL.

Authors:  Melanie Rodrigues; Cecelia C Yates; Austin Nuschke; Linda Griffith; Alan Wells
Journal:  Tissue Eng Part A       Date:  2013-05-01       Impact factor: 3.845

5.  Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population.

Authors:  M Fukunaga-Kalabis; G Martinez; T K Nguyen; D Kim; A Santiago-Walker; A Roesch; M Herlyn
Journal:  Oncogene       Date:  2010-08-23       Impact factor: 9.867

6.  Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis.

Authors:  Manuel A Pallero; Carrie A Elzie; Jiping Chen; Deane F Mosher; Joanne E Murphy-Ullrich
Journal:  FASEB J       Date:  2008-07-24       Impact factor: 5.191

7.  Tenascin-C enhances pancreatic cancer cell growth and motility and affects cell adhesion through activation of the integrin pathway.

Authors:  Igor Paron; Sonja Berchtold; Julia Vörös; Madhavi Shamarla; Mert Erkan; Heinz Höfler; Irene Esposito
Journal:  PLoS One       Date:  2011-06-29       Impact factor: 3.240

8.  No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone.

Authors:  Elisabeth F P Peterse; Arjen H G Cleven; Yvonne De Jong; Inge Briaire-de Bruijn; Jonathan A Fletcher; Erik H J Danen; Anne-Marie Cleton-Jansen; Judith V M G Bovée
Journal:  BMC Cancer       Date:  2016-07-14       Impact factor: 4.430

Review 9.  Chondrosarcoma: A Rare Misfortune in Aging Human Cartilage? The Role of Stem and Progenitor Cells in Proliferation, Malignant Degeneration and Therapeutic Resistance.

Authors:  Karen A Boehme; Sabine B Schleicher; Frank Traub; Bernd Rolauffs
Journal:  Int J Mol Sci       Date:  2018-01-21       Impact factor: 5.923

10.  Expression Changes and Impact of the Extracellular Matrix on Etoposide Resistant Human Retinoblastoma Cell Lines.

Authors:  Jacqueline Reinhard; Natalie Wagner; Miriam M Krämer; Marvin Jarocki; Stephanie C Joachim; H Burkhard Dick; Andreas Faissner; Vinodh Kakkassery
Journal:  Int J Mol Sci       Date:  2020-06-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.